ABOUT
Meet our Board of Directors
Experienced leaders providing strategic direction and oversight for Thryv Therapeutics as it develops next-generation precision therapies for inherited channelopathies, cardiometabolic diseases and cardiomyopathies.
Directors
Paul F. Truex, MBA
CHAIRMAN OF THE BOARD & CHIEF EXECUTIVE OFFICER
Read biography →
Robert Booth, PhD
DIRECTOR
Read biography →
Daniel Hétu, MD, MBA
DIRECTOR
Read biography →
Melissa Koomey, MBA
DIRECTOR
Read biography →
Jean-François Pariseau, MSc, MBA, ICD.D
DIRECTOR
Read biography →